These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 4183291)

  • 21. [STUDIES WITH THE VARICELLA-HERPES ZOSTER VIRUS].
    SOELTZ-SZOETS J
    Arch Klin Exp Dermatol; 1965 Mar; 221():456-62. PubMed ID: 14272390
    [No Abstract]   [Full Text] [Related]  

  • 22. The etiologic agents of varicella and herpes zoster; serologic studies with the viruses as propagated in vitro.
    WELLER TH; WITTON HM
    J Exp Med; 1958 Dec; 108(6):869-90. PubMed ID: 13598817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the specificity of the complement fixation test in cytomegalovirus infections. With special reference to possible cross-reactions with other herpesvirus antigens.
    Andersen HK; Godtfredsen A; Spencer ES
    Scand J Infect Dis; 1971; 3(3):183-7. PubMed ID: 4331836
    [No Abstract]   [Full Text] [Related]  

  • 24. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls.
    Wrensch M; Weinberg A; Wiencke J; Miike R; Sison J; Wiemels J; Barger G; DeLorenze G; Aldape K; Kelsey K
    Am J Epidemiol; 2005 May; 161(10):929-38. PubMed ID: 15870157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Varicella virus isolation from spinal ganglion.
    Shibuta H; Ishikawa T; Hondo R; Aoyama Y; Kurata K; Matumoto M
    Arch Gesamte Virusforsch; 1974; 45(4):382-5. PubMed ID: 4374161
    [No Abstract]   [Full Text] [Related]  

  • 26. Biologic and immunologic characterization of the soluble skin-test antigen of varicella-zoster virus.
    Shiraki K; Yamanishi K; Takahashi M
    J Infect Dis; 1984 Apr; 149(4):501-4. PubMed ID: 6327833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Varicella-Zoster Immunoglobulins during Varicella, Latency, and Zoster.
    Brunell PA; Gershon AA; Uduman SA; Steinberg S
    J Infect Dis; 1975 Jul; 132(1):49-54. PubMed ID: 169308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The serological relationship of varicella-zoster virus to other primate herpesviruses.
    Harbour DA; Caunt AE
    J Gen Virol; 1979 Nov; 45(2):469-77. PubMed ID: 232132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation of varicella-herpes zoster immunoglobulin.
    Janot C; Stoltz JF; Avenard G; Perrier P; Schooneman F; Streiff F
    Transfusion; 1981; 21(6):732-4. PubMed ID: 6274067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Characteristics of the complement-fixing antibody response for varicella-zoster virus in patients with herpes zoster].
    Trivello R; Peserico A; Moschen ME; Romano M
    Ann Sclavo; 1977; 19(6):1133-43. PubMed ID: 218503
    [No Abstract]   [Full Text] [Related]  

  • 31. Humoral and cellular immunity to varicella-zoster virus: an overview.
    Arvin AM
    J Infect Dis; 2008 Mar; 197 Suppl 2():S58-60. PubMed ID: 18419410
    [No Abstract]   [Full Text] [Related]  

  • 32. Detection of varicella-zoster virus-specific IgA antibodies in varicella and zoster patients and in healthy adults of various ages by solid-phase radioimmunoassay.
    Levy E; Mosovitz B; Friedman M; Sarov I
    Intervirology; 1983; 20(2-3):123-8. PubMed ID: 6313543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody to early antigens of varicella-zoster virus during varicella and zoster.
    Gerna G; Cereda PM; Cattaneo E; Achilli G; Gerna MT
    J Infect Dis; 1979 Jul; 140(1):33-41. PubMed ID: 88490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A COMPLEMENT-FIXING ANTIGEN FOR VARICELLA-ZOSTER DERIVED FROM INFECTED CULTURES OF HUMAN FETAL DIPLOID CELLS.
    SCHMIDT NJ; LENNETTE EH; SHON CW; SHINOMOTO TT
    Proc Soc Exp Biol Med; 1964 May; 116():144-9. PubMed ID: 14200088
    [No Abstract]   [Full Text] [Related]  

  • 35. Relationship between serum anti-varicella zoster virus antibody titer and time from onset of herpes zoster.
    Ihara H; Miyachi M; Imafuku S
    J Dermatol; 2018 Feb; 45(2):189-193. PubMed ID: 29239011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention and control of varicella-zoster infections.
    Judelsohn RG
    J Infect Dis; 1972 Jan; 125(1):82-4. PubMed ID: 4109437
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of 4 serological tests--complement fixation, neutralization, fluorescent antibody to membrane antigen and immune adherence hemagglutination--for assay of antibody to varicella-zoster (V-Z) virus.
    Yamada A; Ogino S; Asano Y; Otsuka T; Takahashi M; Baba K; Yabuuchi H
    Biken J; 1979 Jun; 22(2):55-60. PubMed ID: 231433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of varicella by zoster immune globulin.
    Brunell PA; Ross A; Miller LH; Kuo B
    N Engl J Med; 1969 May; 280(22):1191-4. PubMed ID: 4181206
    [No Abstract]   [Full Text] [Related]  

  • 39. Rapid diagnosis of varicella-zoster infections by agar-gel diffusion.
    Uduman SA; Gershon AA; Brunell PA
    J Infect Dis; 1972 Aug; 126(2):193-5. PubMed ID: 4340928
    [No Abstract]   [Full Text] [Related]  

  • 40. Medical students and community physicians also susceptible to varicella-zoster virus.
    Murray DL
    Infect Control; 1987 Feb; 8(2):48. PubMed ID: 3030950
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.